1. Activity of DU-6859a, Ciprofloxacin, Ofloxacin, Levofloxacin, Sparfloxacin and OPC-17116 against 112 Penicillin-Susceptible and -Resistant Pneumococci

   • G. A. Pankuch
   • M. R. Jacobs
   • Peter C. Appelbaum

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 235 - 237

2. The Antimicrobial Activity of Sparfloxacin, a New Quinolone

   • A. G. Paradelis
   • K. Delidou
   • A. Pangalis

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 238 - 239

3. In Vitro and In Vivo Antibacterial Activities of CFC-222, a Novel Broad Spectrum Fluoroquinolone

   • K. H. Park
   • I. H. Cho
   • T. Nishino

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 240 - 242

4. In Vitro Susceptibility of Mycoplasmas to a New Quinolone, BAY Y 3118

   • H. Renaudin
   • Christiane Bébéar

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 243 - 245

5. In Vitro Activity of Ofloxacin, Ciprofloxacin, and Cefoperazone Alone and in Combination against Xanthomonas maltophilia

   • T. A. Ristow
   • L. R. Peterson
   • J. B. Kahn

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 246 - 249

6. In Vitro and In Vivo Activities of Sparfloxacin in Legionella Infections

   • Atsushi Saito
   • Michihiro Gaja

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 250 - 252

7. Study of the Effects of AM-1155 in a Rat Chronic Respiratory Tract Infection Model with Pseudomonas aeruginosa

   • A. Sato
   • H. Kitazawa
   • M. Iwata

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 253 - 255

8. In Vitro Activity of Sparfloxacin against Selected Gram-Negative Blood Culture Isolates

   • Y. Siristonpun
   • V. Rojnpisarnvong
   • Deja Tanphaichitra

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 256 - 256

9. Antichlamydial Activities of Newly Developed Fluoroquinolones and their Potential Future Role in the Treatment of Chlamydial Respiratory Infections

   • Rinzo Soejima
   • Yoshihito Niki
   • Yoshifumi Kubota

   In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 257 - 259

10. In Vitro Activity of Tosufloxacin against Pseudomonas pseudomallei, Salmonella spp. and Other Enterobacteriaceae

    • S. Srimuang
    • V. Fugpholngam
    • D. Tanphaichitra

    In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 260 - 260

11. Evaluation of the Activity of Different Quinolones in the Experimental Chlamydial Salpingitis Mouse Model

    • D. Thomas
    • Jeanne Orfila
    • E. Bissac

    In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 261 - 263

12. Comparative In Vitro Activity of BAY Y 3118 against Selected Species

    • L. Verbist
    • J. Verhaegen

    In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 264 - 265

13. Antimicrobial Evaluation of Nadifloxacin (OPC-7251), a New Topical Quinolone, in Acne Vulgaris

    • Konstanze Vogt
    • H. Hahn
    • C. E. Orfanos

    In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 266 - 268

14. Comparison of the Pharmacodynamic Properties of Quinolones

    • B. Wiedemann
    • C. Rustige-Wiedemann
    • B. Kratz

    In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 269 - 271

15. In Vitro Activity of MF 5137, a New Potent 6-Aminoquinolone

    • R. Wise
    • P. G. Pagella
    • O. Tabarrini

    In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 272 - 273

16. In Vitro Antibacterial Activity of Levofloxacin

    • Ying-Yuan Zhang
    • Fu Wang
    • Le Zhou

    In Vitro and In Vivo Antibacterial Activity 28 November 2012 Pages: 274 - 275

17. Effect of Subinhibitory Concentrations of Pefloxacin in Infection in Mice Due to Susceptible or Resistant Strains

    • H. Carsenti-Etesse
    • M. Bensoussan
    • P. Dellamonica

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 276 - 278

18. Expression of β₁-Integrins on Epiphyseal Chondrocytes Is Reduced by Ofloxacin

    • Christian Förster
    • Mehdi Shakibaei
    • Ralf Stahlmann

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 279 - 282

19. Evaluation of Photosensitising Ability of Quinolones in Guinea-Pigs

    • Takeshi Horio
    • Kohachi Kamada
    • Mikako Ishihara

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 283 - 285

20. Effect of Inhibitors of Protein Kinase C on Enhanced Superoxide Production of Human Leucocytes by Ofloxacin and Fleroxacin

    • Tetsuro Matsumoto
    • Koichi Takahashi
    • Joichi Kumazawa

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 286 - 288

21. Restorative Effect of Ofloxacin on Inhibited Chemiluminescence Response of PMNs by Sera from Uraemic Patients

    • Tetsuro Matsumoto
    • K. Takahashi
    • J. Kumazawa

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 289 - 290

22. Absence of Neuromuscular Blocking Activity of Sparfloxacin

    • A. G. Paradelis
    • D. Kouvelas
    • G. Salpigides

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 291 - 292

23. Ofloxacin Alters Expression of Integrins on Chondrocytes from Mouse Fetuses In Vitro

    • Mehdi Shakibaei
    • Christian Förster
    • Ralf Stahlmann

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 293 - 295

24. In Vitro Effect of Ciprofloxacin and Ofloxacin on Murine and Human Colon Carcinoma Cell Lines

    • Itamar Shalit
    • N. Nasrallah
    • M. Rabau

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 296 - 297

25. Effect of Ciprofloxacin on Cholinergic Neuro-Effector Transmission in Airway Smooth Muscle

    • Jun Tamaoki
    • Etsuko Tagaya
    • Kimio Konno

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 298 - 300

26. Effect of Ciprofloxacin and Other Quinolones on Granulocyte Function Assessed By Flow Cytometry

    • C. Wenisch
    • P. Parschalk
    • W. Graninger

    Miscellaneous Pharmacology and Toxicology Studies 28 November 2012 Pages: 301 - 303

27. Release of Pefloxacin Bonded on Catheters after Intraperitoneal Implantation in Mice

    • H. Carsenti-Etesse
    • B. Forget
    • P. Dellamonica

    Pharmacokinetics 28 November 2012 Pages: 304 - 306

28. Sparfloxacin Secretion across Caco-2 Cells Involves a Multidrug Resistance-Like Mechanism

    • E. Cormet
    • A. M. Burlier
    • D. Tomé

    Pharmacokinetics 28 November 2012 Pages: 307 - 309

29. Comparison of Models for Studying the Intestinal Elimination of Ciprofloxacin in the Rat

    • Sophie Dautrey
    • L. Rabbaa
    • R. Farinotti

    Pharmacokinetics 28 November 2012 Pages: 310 - 311

30. Pharmacokinetics of Ofloxacin — Measurement of Drug Concentration in Saliva of Patients with Impaired Renal Function

    • K. Fujita
    • N. Matsuoka
    • K. Akiyama

    Pharmacokinetics 28 November 2012 Pages: 312 - 313

31. Differences between Albino and Pigmented Rabbit Eyes in the Intraocular Pharmacokinetics of Sparfloxacin

    • Masamichi Fukuda
    • Kazuyuki Sasaki

    Pharmacokinetics 28 November 2012 Pages: 314 - 316

32. Comparative Assessment of the Pharmacokinetics and Pharmacodynamics of Ciprofloxacin after Single IV Doses of 200 and 400mg

    • R. Garraffo
    • H. B. Drugeon

    Pharmacokinetics 28 November 2012 Pages: 317 - 320

33. Pharmacokinetics of CFC-222 in Animals

    • Y. H. Jung
    • K. S. Lee
    • K. H. Park

    Pharmacokinetics 28 November 2012 Pages: 321 - 322

34. Pharmacokinetic Study of a New Quinolone, DW-116

    • Dug-Keun Lee

    Pharmacokinetics 28 November 2012 Pages: 323 - 325

35. NM441: Penetration into Gynaecological Tissues and In Vitro Activity against Clinical Isolates from Obstetric and Gynaecological Patients

    • Hiroshige Mikamo
    • Kyoko Kawazoe
    • Teruhiko Tamaya

    Pharmacokinetics 28 November 2012 Pages: 326 - 330

36. Excretion of New Quinolones and their Glucuronide Conjugates into Human Bile

    • Koichi Murakami
    • H. Tanimura
    • K. Iwakura

    Pharmacokinetics 28 November 2012 Pages: 331 - 332

37. Stereoselectivity of Ofloxacin Intestinal Transport in the Rat

    • Lydia Rabbaa
    • S. Dautrey
    • R. Farinotti

    Pharmacokinetics 28 November 2012 Pages: 333 - 334

38. Pharmacokinetics of T-3761 in Healthy Volunteers

    • Akira Saito

    Pharmacokinetics 28 November 2012 Pages: 335 - 336

39. Penetration of NM441, a New Quinolone, into Human Bile and Gallbladder Tissue

    • H. Tanimura
    • K. Ishimoto
    • S. Iwakura

    Pharmacokinetics 28 November 2012 Pages: 337 - 340

40. Gallbladder Tissue Concentrations, Biliary Excretion and Pharmacokinetics of OPC-17116

    • Hiroshi Tanimura
    • Kazuhisa Uchiyama
    • Hideo Kashiwagi

    Pharmacokinetics 28 November 2012 Pages: 341 - 343

41. The Pharmacokinetics and Distribution of Ofloxacin into the Lower Respiratory Tract

    • R. A. Walstad
    • J. S. Vilsvik
    • T. Rolstad

    Pharmacokinetics 28 November 2012 Pages: 344 - 345

42. The Effect of Milk Consumption on the Pharmacokinetics of Fleroxacin and Ciprofloxacin in Healthy Volunteers

    • J. F. W. Hoogkamer
    • C. H. Kleinbloesem

    Pharmacokinetics 28 November 2012 Pages: 346 - 348

43. Effect of Fenbufen on the Penetration of Quinolone Antibiotics into Cerebrospinal Fluid

    • K. Iwamoto
    • N. Ichikawa
    • H. Hirano

    Pharmacokinetics 28 November 2012 Pages: 349 - 351

44. Effect of Ferrous Sulfate on the Absorption of Sparfloxacin in Healthy Volunteers and Rats

    • Keiji Kanemitsu
    • S. Hori
    • J. Shimada

    Pharmacokinetics 28 November 2012 Pages: 352 - 356

45. The Effect of Fleroxacin and Ciprofloxacin on the Pharmacokinetics of Multiple Dose Caffeine

    • David P. Nicolau
    • Charles H. Nightingale
    • Richard Quintiliani

    Pharmacokinetics 28 November 2012 Pages: 357 - 359

46. Effects of Antacid on Absorption and Excretion of New Quinolones

    • Kohya Shiba
    • Mitsuo Sakamoto
    • Osamu Sakai

    Pharmacokinetics 28 November 2012 Pages: 360 - 361

47. Evaluation of Clinical Efficacy of Antimicrobials in Complicated Urinary Tract Infections

    • Y. Kawada
    • S. E. Lee
    • T. Doi

    Therapeutic Use 28 November 2012 Pages: 362 - 364

48. Comparative Efficacies of Oral Pefloxacin in Uncomplicated Cystitis

    • Amorn Leelarasamee
    • Imjai Leelarasamee

    Therapeutic Use 28 November 2012 Pages: 365 - 367

49. A Randomised Controlled Trial of Ofloxacin 200mg 4 Times Daily or Twice Daily vs Ciprofloxacin 500mg Twice Daily in Elderly Nursing Home Patients with Complicated UTI

    • Jack D. McCue
    • Philip Gaziano
    • Dorothy Orders

    Therapeutic Use 28 November 2012 Pages: 368 - 373

50. Effectiveness of Ofloxacin Therapy in Preventing Functional Impairment and Increased Mortality in Elderly Patients with Bacteriuria

    • M. Staszewska-Pistoni
    • A. S. Dontas
    • P. Zorbas

    Therapeutic Use 28 November 2012 Pages: 374 - 375